Thanks to a new technology, the diagnosis of brain cancer undergoes a breakthrough. The credit goes to cancer diagnostics company and University of Strathclyde Dxcover spin-out company. The company has indeed launched the liquid biopsy Dxcover, which was also effective in the early days of cancer growth, at a smaller volume and earlier stage.
q
There Research was published in the scientific journal Cancers.
Brain cancer: here are the advantages of the Dxcover liquid biopsy
According to Cancer Research UK, a 12,000 people in Britain are diagnosed with brain cancer each year and survival rates are 12% five years after diagnosis.
Read Also
- Was the State of Play owed? – Atomix Podcast 319 Jul 14, 2021
- Gorilla Glass for cameras, DX and DX + new products Jul 23, 2021
- Why does Pfizer want to give the vaccinators a third dose? Jul 12, 2021
- The beta Android 11 will soon be available on the Oppo Find X2 and on the Find X2 Pro Jun 12, 2020
- Honor folding smartphone: display already in development Jul 14, 2021
- PS5 appears in Australia with a new model Aug 23, 2021
- Hailey Bieber celebrates her 26th birthday in Tokyo with Justin… Jennifer Lopez seems to have a big project underway… Nov 23, 2022